Willow Industries and Abstrax Partner Together to Create New Cannabis Terpene Infusion System
Willow Industries and Abstrax announce new cannabis terpene infusion system called HALO.
Image | adobe.stock/EpicStockMedia
In a recent press release (1), Willow Industries, a company involved in cannabis decontamination technology and control services, announced that through a partnership with Abstrax, a company involved in cannabis and terpene research, together created HALO. This device is “a closed-loop system that revolutionizes the way cannabis flower is infused with terpenes. The machine employs a precise and controlled infusion process that aerosolizes liquid terpenes to optimize distribution, minimize waste, and maximize efficiency,” (1). HALO provides a variety of beneficial offerings such as, advanced tracking software, an enclosed drum loading system, customizable settings, and minimal labor requirements.
Some of the key features and benefits of HALO, as mentioned in the press release are (1):
- Efficiency: Optimizes the infusion process, reducing time and labor compared to manual application methods.
- Consistency: Delivers uniform terpene coverage, ensuring each batch meets high-quality standards.
- Controlled Environment: Reduces risks of cross-contamination through a clean, enclosed application system.
HALO’s device dimensions are 52" W x 48" L x 63" H.Power specifications are 110 VAC 50/60 Hz 15A and in regard to processing time, HALO is able to perform within 30 minutes, an infusion and a cleaning cycle (1).
“Our goal at Willow Industries has always been to raise the bar for quality and safety in the cannabis industry,” Jill Ellsworth, Founder and CEO of Willow Industries, explained (1). “We're incredibly excited to partner with Abstrax to bring HALO to the market. By combining cutting-edge science with innovative engineering, HALO brings a revolutionary terpene infusion system that delivers precision, consistency, and safety. Together, we're setting a new standard for cannabis quality and innovation.”
“Through this collaboration, Abstrax and Willow are innovating to set a new standard,” Kevin Koby, CEO of Abstrax, said (1). “HALO represents a major step forward in how we approach terpene infusion. By harnessing Abstrax's expertise and the precision of the HALO system, operators can now create products with unmatched consistency and safety, all while elevating the cannabis experience. We're thrilled to be at the forefront of this industry.”
Reference
- Willow Industries. Willow Industries and ABSTRAX unveil revolutionary cannabis terpene infusion system https://www.prnewswire.com/news-releases/willow-industries-and-abstrax-unveil-revolutionary-cannabis-terpene-infusion-system-302364561.html (accessed Feb 5, 2025).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
